clinical trial · NCT00658879
Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan
Pfizer·—·completed·n = 251
AcromegalySomavert (Pegvisomant)
brief summary
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3)factors considered to affect the safety and/or efficacy of this drug.
started
Aug 7, 2007
primary completion
Nov 9, 2016
completion
Nov 9, 2016
last updated
Sep 25, 2023
detailed description
All the patients whom an investigator prescribes the first Somavert (Pegvisomant) should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.
official title
SPECIAL INVESTIGATION OF SOMAVERT -LONG TERM USE-
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol